Sign In
Buy KRTX
$329.83
+0 (+0%)
At Close: Jun 14, 2024
Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout
12:11pm, Friday, 23'rd Feb 2024
Karuna's (KRTX) fourth-quarter 2023 earnings and revenues miss estimates. The company is set to be acquired by Bristol Myers.
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
06:30am, Thursday, 22'nd Feb 2024
BOSTON--(BUSINESS WIRE)---- $KRTX--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychi
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Karuna Thera
Bullish Continuation in '24? 3 Market Areas to Watch
02:17pm, Wednesday, 10'th Jan 2024
Will stocks continue into 2024? Stock Strategist Andrew Rocco shares his prediction and unveils 3 important market areas to monitor.
Cramer names biopharma companies to watch as industry mergers start to pile up
07:02pm, Friday, 05'th Jan 2024
CNBC's Jim Cramer pointed out the numerous mergers and acquisitions across the biopharma industry.
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Karuna Thera
Yes Virginia, There Is a Santa Claus Rally
06:47pm, Tuesday, 26'th Dec 2023
The Russell is up an astounding +26% from late October, largely thanks to signaled interest rate cuts from the Fed in 2024.
Karuna (KRTX) Up 48% on $14B Buyout Offer From Bristol Myers
12:46pm, Tuesday, 26'th Dec 2023
Bristol Myers (BMY) is set to acquire Karuna (KRTX) for $330 per share. This transaction is expected to close in the first half of 2024.
Nano Dimension Buys Stratasys, Bristol Myers's Shopping Spree, Apple Gets a ‘No'
08:55am, Tuesday, 26'th Dec 2023
The holiday shopping season isn't over yet. A 3-D printing company and a major pharmaceuticals maker announced post-Christmas acquisitions Tuesday morning.
Bristol-Myers buying Karuna signals a biotech boom ahead: Jefferies
04:10pm, Saturday, 23'rd Dec 2023
Karuna Therapeutics Inc (NASDAQ: KRTX) ended nearly 50% up on Friday after Bristol-Myers Squibb Co (NYSE: BMY) said it will buy the biopharmaceutical firm for $14 billion.
Biotech boom ahead in 2024, top Jefferies analyst predicts on heels of Bristol Meyers-Karuna deal
06:29pm, Friday, 22'nd Dec 2023
Michael Yee, Jefferies Senior Biotech Analyst, joins 'Fast Money' to talk a possible boom ahead for the biotech sector.
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Karuna Therapeutics, Inc.
03:30pm, Friday, 22'nd Dec 2023
NEW YORK , Dec. 22, 2023 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Karuna Therapeutics, Inc. (NASDAQ: KRTX) and its board of directors concerning the prop
Bristol Myers Squibb to buy Karuna Therapeutics for $14 billion in cash
01:27pm, Friday, 22'nd Dec 2023
Stephanie Link and Jim Lebenthal join 'Halftime Report' to discuss Bristol Myers Squibb's latest announcement to buy Karuna Therapeutics for $14 billion.
Bristol Myers Squibb buys neurological drug developer Karuna Therapeutics in $14B deal
01:14pm, Friday, 22'nd Dec 2023
Shares of biopharmaceutical company Karuna Therapeutics skyrocketed more than 47% Friday morning after giant Bristol-Myers Squibb Co (NYSE:BMY, ETR:RM, OTC:BMYMP) announced a deal to acquire the compa
Midday Movers: Karuna Jumps on Deal With Bristol Myers Squibb, Nike Falls on Sales Outlook
12:45pm, Friday, 22'nd Dec 2023
U.S. equities headed into the long holiday weekend with gains at midday, amid a broad-based rally fueled by enthusiasm over the possibility of several Fed interest rate cuts next year. The Dow, S&P 50
